{
    "2020-05-06": [
        [
            {
                "time": "",
                "original_text": "药明康德(02359)：WuXi AppTec(BVI)已合计减持1705.23万股 减持股份数",
                "features": {
                    "keywords": [
                        "药明康德",
                        "WuXi AppTec",
                        "减持",
                        "股份数"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2023-05-12",
                "original_text": "药明康德(603259.SH)：330.895万股限制性股票5月12日解禁 解禁",
                "features": {
                    "keywords": [
                        "药明康德",
                        "限制性股票",
                        "解禁"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "药明康德(603259.SH)：WuXi App Inc.持股比例被动稀释至5.84%",
                "features": {
                    "keywords": [
                        "药明康德",
                        "WuXi App",
                        "持股比例",
                        "被动稀释"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "药明康德：股东WuXi AppTec (BVI) Inc.减持超过1% 减持股份",
                "features": {
                    "keywords": [
                        "药明康德",
                        "WuXi AppTec",
                        "减持",
                        "股东"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "北向资金连续6日净流入，贵州茅台获净买入5.74亿元居首",
                "features": {
                    "keywords": [
                        "北向资金",
                        "净流入",
                        "贵州茅台"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "白酒"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "最被看好十大港股:麦格理予药明康德目标价154.51港元",
                "features": {
                    "keywords": [
                        "药明康德",
                        "麦格理",
                        "目标价",
                        "看好"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "麦格理：首予药明康德(02359)“跑赢大市”评级 目标价154.51港元",
                "features": {
                    "keywords": [
                        "药明康德",
                        "麦格理",
                        "跑赢大市",
                        "目标价"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}